ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: It is very well known that the progression of CML in the patients is due to the distinct expression of BCR-ABL gene8 and drugs like imatinib show decrease in this expression and helps reverse the disease to a greater extent.